DHCR7 and Smith-Lemli-Opitz syndrome: Rare loss-of-function mutations in DHCR7 have been previously described and are associated with Smith-Lemli-Opitz syndrome (SLOS), in which affected homozygous individuals have greatly elevated serum 7-dehydrocholesterol levels and correspondingly low serum cholesterol [15].